Dr. Keith Tokuhara on drug rep influence

Dr. Keith Tokuhara, a California ophthalmologist, wrote on X on June 3 that exposure to pharmaceutical sales representatives can start in medical school and become normalized by residency. His post did not cite a study, but it tapped into a long-running debate in medical education about whether early contact with industry shapes how trainees think about drugs, gifts and professional boundaries. Keith Tokuhara’s remarks drew replies from trainees and educators on X, according to the social post and thread. The exchange stayed at the level of lived experience rather than new data, but the underlying question — how early industry influence starts in training — has been studied for years in medical education journals and by physician groups. ### What exactly did Tokuhara say? June 3 was the date Tokuhara posted that drug representatives show up early enough in training that relationships with industry can seem routine by the time doctors reach residency. The framing was straightforward: repeated exposure, not a single event, was the concern. Tokuhara is an ophthalmologist in Rancho Mirage, California, according to physician and practice listings. Public profiles identify him as Keith G. Tokuhara, a board-certified ophthalmologist affiliated with Desert Vision Center and trained at the University of Hawaii and Loma Linda University. ### Is there evidence that exposure starts that early? UCLA researchers reported in a study of pre-clinical medical students that exposure to pharmaceutical marketing “started very early in medical school.” That study, indexed in Medical Education Online, examined first- and second-year students and focused on both exposure and attitudes toward industry marketing. (desertvisioncenter.com) A 2013 study in the Journal of General Internal Medicine also examined trainees across medical school and residency and said medical school policies were increasingly limiting representatives’ access and gifts, while asking how those environments affected attitudes and practices. The paper’s premise matched Tokuhara’s point that the training environment itself matters. (tandfonline.com) ### What do more recent data show about trainee attitudes? JAMA Health Forum published a survey study in 2025 reporting responses from medical students and residents about their interactions with and attitudes toward the pharmaceutical industry, comparing results from 2011 and 2024. The study said it was designed to measure how those views changed over 13 years. (pmc.ncbi.nlm.nih.gov) The American Medical Association, summarizing earlier research, said nearly one in five residents reported getting basic drug information from pharmaceutical sales representatives and other industry sources. That summary also said residents increasingly used peer-reviewed journals and clinical guidelines over the course of training, but industry sources remained part of the information mix. (jamanetwork.com) ### Why has this been such a persistent issue in medical education? The Association of American Medical Colleges said in recommendations cited by conflict-of-interest policy guides that academic medical centers should prohibit industry gifts to faculty, students, trainees and staff. Those materials argued that even small gifts can create a sense of obligation and affect decision-making. (ama-assn.org) The American Medical Association’s ethics code takes a narrower route, saying relationships with drug and device companies can support innovation but must be structured to protect professional judgment and patient trust. Its guidance on gifts sets conditions for what is acceptable. ### What is the practical point of Tokuhara’s post? (communitycatalyst.org) Tokuhara’s June 3 post did not present new research, policy proposals or institutional allegations. What it did was restate, in personal terms, a concern already reflected in published studies: medical school and residency are formative periods, and repeated contact with industry can influence attitudes before prescribing habits are fully formed. (code-medical-ethics.ama-assn.org) The next public record in this story is the reply thread under Tokuhara’s June 3 X post, where trainees and educators responded directly. Any broader policy change would likely come, as in past cycles, through medical school, residency or professional-association rules rather than through the post itself. (communitycatalyst.org) (onlinelibrary.wiley.com)